177Lu-PSMA-617
Novartis
['prostate', 'biomarker', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'marker ']
evaluation of a novel transcriptomic tumor signature #prostest as response biomarker for 177lu-psma therapy in advanced #prostatecancer. presentation by alin chirindel, md . #gu23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology